Bond Screener
CSL
LEI 529900ECSECK5ZDQTE14
Organization name
CSL Limited
Country name
Australia
Country of registration
Australia
Industry
Pharmaceutical Preparation and Biotechnology
Credit Ratings
in foreign currency
Public debt
1,250 mln USD
New to Cbonds? · Take a 90-second tour of the platform.
Discover what you can do with Cbonds
Everything you need for fixed income research and monitoring.
- 00:23 Coverage
- 00:40 Bond screener
- 00:54 Parameters
- 01:10 Watchlist, Mobile app
- 01:15 Excel Add-in
Trading Schedule Issuer map
Quotes
/
/
/
pcs.
pcs.
pcs.
- «
- 1
- ...
- {{ quotes.page - 2 }}
- {{ quotes.page - 1 }}
- {{ quotes.page }}
- {{ quotes.page + 1 }}
- {{ quotes.page + 2 }}
- ...
- {{ quotesLastPage }}
- »
Quotes provided by information providers are indicative in nature
General information
-
Organization nameCSL Limited
-
Organization statusOperating organization
-
Address45 Poplar Road, Parkville Parkville, Australia, 3052
-
Site
News
-
CSL Posts Loss In FY26 On Restructuring Costs, Impairments18/08/2026
-
CSL Sees $5 Bln Non-Cash Impairments, Cuts FY26 Outlook; Stock Plunges11/05/2026
-
Biotech CSL fails at administering own medicine11/02/2026
-
CSL Shares Fall 6.5% on Earnings Miss, Surprise CEO Change11/02/2026
-
CSL Posts Higher Fiscal H1 Earnings, Revenue; Reaffirms Outlook10/02/2025
IFRS/US GAAP reports
| 2026 | |
| 2025 | |
| 2024 | |
| 2023 | |
| 2022 | |
| 2021 | |
| 2020 | |
| 2019 | |
Show more
Hide
Authorization required
You need to request access
Stocks
General information
-
Organization nameCSL Limited
-
Organization statusOperating organization
-
Address45 Poplar Road, Parkville Parkville, Australia, 3052
-
Site
Codes
-
LEI529900ECSECK5ZDQTE14
-
SIC2836 BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
-
NACE*** ***
-
NAICS*** ***
-
CIK0001274152
-
TFN051 588 348
